ZIKAlliance Natural History Study
NCT03204409 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2022-05-18
Summary
Study to enroll up to 1000 adult patients (\>18 years) presenting with febrile or rash illness of short duration (\<72h) in designated clinics in the State of Sao Paulo, Brazil.
Conditions
- Zika Virus
- Zika Virus Infection
Sponsors & Collaborators
-
University of Sao Paulo
collaborator OTHER -
University of Heidelberg Medical Center
lead OTHER
Principal Investigators
-
Thomas Jänisch · University Hospital Heidelberg
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-04-01
- Primary Completion
- 2021-09-30
- Completion
- 2021-09-30
Countries
- Brazil
Study Locations
More Related Trials
-
Tocilizumab Dose-tapering and Interruption in Patients With Giant Cell Arteritis Achieving the Clinical Remission.
NCT03244709 ·Status: UNKNOWN ·Phase: PHASE4
-
Methotrexate as Remission Maintenance Therapy After Remission-Induction With Tocilizumab and Glucocorticoids in Giant Cell Arteritis
NCT05623592 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Halo Sign Vanishing Time After Steroids Outbreak in GCA Patients
NCT07060274 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Evaluation of the Immune Response to Sars-Covid-19 Vaccines in Haematological Patients: Prospective Single Center Study
NCT05074706 ·Status: COMPLETED
-
Establishing a COVID-19 Prospective Cohort for Identification of Secondary HLH
NCT04347460 ·Status: UNKNOWN
-
Maintenance of ANCA Vasculitis Remission by Intermittent Rituximab Dosing
NCT02749292 ·Status: TERMINATED ·Phase: PHASE4
-
Methylprednisolone Pulse Therapy for Coronary Artery Dilatation or Aneurysm Formation in Kawasaki Disease
NCT04509219 ·Status: UNKNOWN ·Phase: PHASE1
-
Efficacy of Steroid Versus Steroid Plus Cyclophosphamide for Severe Henoch-Schoenlein Purpura
NCT00190229 ·Status: COMPLETED ·Phase: NA
-
Steroids and Methotrexate to Treat Systemic Vasculitis
NCT00001256 ·Status: COMPLETED ·Phase: PHASE2
-
Study of NM8074 in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV)
NCT06226662 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Tocilizumab and Tofacitinib in the Treatment of Vascular Behçet's Syndrome
NCT05845723 ·Status: RECRUITING ·Phase: PHASE2
-
Measurement of Antibodies in Adults With a History of Kawasaki Disease
NCT02853266 ·Status: UNKNOWN
-
Splenectomy as a Treatment for Patient With Relapsed Haemophagocytic Lymphohistiocytosis of Unknown Etiology
NCT02862054 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Tocilizumab Plus a Short Prednisone Taper for GCA
NCT03726749 ·Status: COMPLETED ·Phase: PHASE4
-
Contrast-Enhanced US of Spleen, Liver and Kidney
NCT00190281 ·Status: UNKNOWN
-
Efficacy of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesion in Patients With Kawasaki Disease
NCT04078568 ·Status: COMPLETED ·Phase: PHASE3
-
Kawasaki Disease During the COVID-19 Epidemic
NCT06309303 ·Status: COMPLETED
-
Giant Cell Arteritis Treatment With Ultra-short Glucocorticoids and Tocilizumab
NCT03745586 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Rituximab Plus Corticosteroids in Non-infectious Active Mixed Cryoglobulinemia Vasculitis
NCT02556866 ·Status: TERMINATED ·Phase: PHASE2
-
Plasma Exchange for Renal Vasculitis
NCT01408836 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Temporal Artery Biopsy vs ULtrasound in Diagnosis of GCA (TABUL)
NCT00974883 ·Status: COMPLETED
-
Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)
NCT02592798 ·Status: COMPLETED ·Phase: PHASE2
-
A Prospective Study on Optimizing Treatment for ABPA
NCT05129033 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Anti-CD20 Antibodies (Rituximab Biosimilar) in the Treatment of Childhood Steroid-dependent Nephrotic Syndrome
NCT04402580 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease
NCT00685373 ·Status: COMPLETED ·Phase: PHASE3